Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Tribble Diane L. — Aegerion Pharmaceuticals, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Tribble Diane L.

Tribble Diane L.

Chief Scientific Officer at Aegerion Pharmaceuticals, Inc. · on record since Feb 23, 2011

Insider trading activity of Tribble Diane L.

Transactions on record: 1; since Mar 2, 2011

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Mar 2, 2011

Figures computed from official regulatory filings — methodology.

Companies where Tribble Diane L. has traded

Aegerion Pharmaceuticals, Inc.1 tx · Mar 2, 2011

Track record of Tribble Diane L.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Tribble Diane L.

Co-insiders of Tribble Diane L.

Advent Healthcare & Life Sciences III-A Limited PartnershipAegerion Pharmaceuticals, Inc.
ADVENT HEALTHCARE & LIFE SCIENCES III LIMITED PARTNERSHIPAegerion Pharmaceuticals, Inc.
ADVENT INTERNATIONAL CORP/MAAegerion Pharmaceuticals, Inc.
ADVENT INTERNATIONAL LLCAegerion Pharmaceuticals, Inc.
Advent Partners HLS III Limited PartnershipAegerion Pharmaceuticals, Inc.
AHLS III GP LIMITED PARTNERSHIPAegerion Pharmaceuticals, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

ALTA BIOPHARMA MANAGEMENT III LLCAegerion Pharmaceuticals, Inc.

ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KGAegerion Pharmaceuticals, Inc.

ALTA BIOPHARMA PARTNERS III LPAegerion Pharmaceuticals, Inc.

ALTA EMBARCADERO BIOPHARMA PARTNERS III LLCAegerion Pharmaceuticals, Inc.

Andrews William T.Aegerion Pharmaceuticals, Inc.

Aubuchon DavidAegerion Pharmaceuticals, Inc.

BARER SOL JAegerion Pharmaceuticals, Inc.

Beer Marc DAegerion Pharmaceuticals, Inc.

Broadfin Capital, LLCAegerion Pharmaceuticals, Inc.

Broadfin Healthcare Master Fund LtdAegerion Pharmaceuticals, Inc.

Buono LindaAegerion Pharmaceuticals, Inc.

CARTER MARTHA JAegerion Pharmaceuticals, Inc.

Cavan John TAegerion Pharmaceuticals, Inc.

CHAMPSI FARAHAegerion Pharmaceuticals, Inc.

Chan Barbara YAegerion Pharmaceuticals, Inc.

Cook Anne MarieAegerion Pharmaceuticals, Inc.

Curtis EricAegerion Pharmaceuticals, Inc.

DELEAGE JEANAegerion Pharmaceuticals, Inc.

EDELMAN JOSEPHAegerion Pharmaceuticals, Inc.

FISHERMAN JASON SAegerion Pharmaceuticals, Inc.

Fitzpatrick Mark J.Aegerion Pharmaceuticals, Inc.

Fraser CraigAegerion Pharmaceuticals, Inc.

GOTTO ANTONIO M JR MD D PHILAegerion Pharmaceuticals, Inc.

Harshbarger BenjaminAegerion Pharmaceuticals, Inc.

HURWITZ EDWARDAegerion Pharmaceuticals, Inc.

Index Venture Associates III LtdAegerion Pharmaceuticals, Inc.

Index Ventures III (Delaware) L.P.Aegerion Pharmaceuticals, Inc.

Index Ventures III (Jersey) L.P.Aegerion Pharmaceuticals, Inc.

Index Ventures III Parallel Entrepreneur Fund (Jersey) L.P.Aegerion Pharmaceuticals, Inc.

KOTLER KEVINAegerion Pharmaceuticals, Inc.

Lewis WilliamAegerion Pharmaceuticals, Inc.

Louis RogerAegerion Pharmaceuticals, Inc.

Menes Remi AAegerion Pharmaceuticals, Inc.

Ollier MicheleAegerion Pharmaceuticals, Inc.

ORLOFF JOHN JAegerion Pharmaceuticals, Inc.

PELLIZZARI CHRISTINE AAegerion Pharmaceuticals, Inc.

PENHOET EDWARDAegerion Pharmaceuticals, Inc.

PERCEPTIVE ADVISORS LLCAegerion Pharmaceuticals, Inc.

PERCEPTIVE LIFE SCIENCES MASTER FUND LTDAegerion Pharmaceuticals, Inc.

PERRY GREGORY DAegerion Pharmaceuticals, Inc.

Peyromaure de Bord AlisonAegerion Pharmaceuticals, Inc.

Plutzky Jorge MDAegerion Pharmaceuticals, Inc.

QLT INC/BCAegerion Pharmaceuticals, Inc.

Rothera MarkAegerion Pharmaceuticals, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Aegerion Pharmaceuticals, Inc.	Mar 2, 2011	AwardD	220,000	0.00 USD	$0	SEC